SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18666232
Source:
http://linkedlifedata.com/resource/pubmed/id/18666232
Search
Subject
(
65
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0017431
,
umls-concept:C0035525
,
umls-concept:C0042769
,
umls-concept:C0087111
,
umls-concept:C0205191
,
umls-concept:C0220847
,
umls-concept:C0369335
,
umls-concept:C0439228
,
umls-concept:C0439458
,
umls-concept:C0982327
pubmed:issue
2
pubmed:dateCreated
2008-8-5
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8302946
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols
,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a
,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1527-3350
pubmed:author
pubmed-author:AlsiöAsaA
,
pubmed-author:BuhlMads RauningMR
,
pubmed-author:ChristensenPeerP
,
pubmed-author:DhillonAmar PAP
,
pubmed-author:FärkkiläMarttiM
,
pubmed-author:HellstrandKristofferK
,
pubmed-author:LaggingMartinM
,
pubmed-author:LangelandNinaN
,
pubmed-author:LeutscherPeterP
,
pubmed-author:MørchKristineK
,
pubmed-author:NORDynamIC Study Group
,
pubmed-author:NorkransGunnarG
,
pubmed-author:PedersenCourtC
,
pubmed-author:WestinJohanJ
pubmed:issnType
Electronic
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
695
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18666232-Antiviral Agents
,
pubmed-meshheading:18666232-Body Weight
,
pubmed-meshheading:18666232-Dose-Response Relationship, Drug
,
pubmed-meshheading:18666232-Drug Administration Schedule
,
pubmed-meshheading:18666232-Drug Therapy, Combination
,
pubmed-meshheading:18666232-Genotype
,
pubmed-meshheading:18666232-Hepacivirus
,
pubmed-meshheading:18666232-Hepatitis C, Chronic
,
pubmed-meshheading:18666232-Humans
,
pubmed-meshheading:18666232-Interferon-alpha
,
pubmed-meshheading:18666232-Polyethylene Glycols
,
pubmed-meshheading:18666232-RNA, Viral
,
pubmed-meshheading:18666232-Recombinant Proteins
,
pubmed-meshheading:18666232-Ribavirin
,
pubmed-meshheading:18666232-Time Factors
pubmed:year
2008
pubmed:articleTitle
Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection.
pubmed:publicationType
Letter